Darryl McDougald

Preclinical Evaluation of ¹⁸F-Labeled Anti-HER2 Nanobody Conjugates for Imaging HER2 Receptor Expression by Immuno-PET

Ganesan Vaidyanathan, Darryl McDougald, Jae‐Yeon Choi et al. · Journal of Nuclear Medicine · 2016 · 87 citations · Full text

Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases.

James G. Conway, Robert Andrews, B Beaudet et al. · PubMed · 2001 · 75 citations

Dual Inhibitor, Soluble Tnf, Tnf-alpha-converting Enzyme +20

Design of Selective and Soluble Inhibitors of Tumor Necrosis Factor-α Converting Enzyme (TACE)

Michael H. Rabinowitz, Robert Andrews, J. David Becherer et al. · Journal of Medicinal Chemistry · 2001 · 73 citations · Full text

Inhibitory Activity, Medicinal Chemistry, Pharmaceutical Science +15

Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical Evaluation

Zhengyuan Zhou, Ganesan Vaidyanathan, Darryl McDougald et al. · Molecular Imaging and Biology · 2017 · 65 citations · Full text

Immunocytochemical Technique, Residualizing Label, Immunology +9

Structure-Based Design of Potent Retinoid X Receptor α Agonists

Curt D. Haffner, James M. Lenhard, Aaron B. Miller et al. · Journal of Medicinal Chemistry · 2004 · 48 citations · Full text